Multiple Myeloma

MD IQ

News

Ixazomib improves PFS after ASCT in MM

SAN DIEGO—Ixazomib improved progression-free survival (PFS) following autologous stem cell transplant (ASCT) in patients with newly diagnosed...

Pages